Cargando…

Drug Repurposing for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer which presents a high rate of relapse, metastasis, and mortality. Nowadays, the absence of approved specific targeted therapies to eradicate TNBC remains one of the main challenges in clinical practice. Drug discovery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ávalos-Moreno, Marta, López-Tejada, Araceli, Blaya-Cánovas, Jose L., Cara-Lupiañez, Francisca E., González-González, Adrián, Lorente, Jose A., Sánchez-Rovira, Pedro, Granados-Principal, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711505/ https://www.ncbi.nlm.nih.gov/pubmed/33138097 http://dx.doi.org/10.3390/jpm10040200

Ejemplares similares

Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
por: Griñan-Lison, Carmen, et al.
Publicado: (2021)

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression
por: López-Tejada, Araceli, et al.
Publicado: (2023)

Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
por: Navarro-Ocón, Alba, et al.
Publicado: (2022)

Repurposing of drugs for triple negative breast cancer: an overview
por: Spini, Andrea, et al.
Publicado: (2020)

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
por: Granados-Principal, Sergio, et al.
Publicado: (2015)

GARP is a key molecule for mesenchymal stromal cell responses to TGF‐β and fundamental to control mitochondrial ROS levels
por: Carrillo‐Gálvez, Ana Belén, et al.
Publicado: (2020)

Repurposing Terfenadine as a Novel Antigiardial Compound
por: Suárez-Rico, Daniel Osmar, et al.
Publicado: (2023)

Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer
por: Kourti, Malamati, et al.
Publicado: (2019)

Update on systemic treatment in early triple negative breast cancer
por: Núñez Abad, Martín, et al.
Publicado: (2021)

A plasma metabolomic signature discloses human breast cancer
por: Jové, Mariona, et al.
Publicado: (2017)

HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway
por: Liu, Yi, et al.
Publicado: (2017)

Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021)

Diets Based on Virgin Olive Oil or Fish Oil but Not on Sunflower Oil Prevent Age-Related Alveolar Bone Resorption by Mitochondrial-Related Mechanisms
por: Bullon, Pedro, et al.
Publicado: (2013)

A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer
por: Vitali, Francesca, et al.
Publicado: (2016)

Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide
por: Bhattacharya, Udayan, et al.
Publicado: (2023)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer
por: Vitali, Francesca, et al.
Publicado: (2017)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis
por: El-Dirany, Rima, et al.
Publicado: (2022)

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
por: Aspros, Kirsten G. M., et al.
Publicado: (2022)

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Martin, Miguel, et al.
Publicado: (2021)

Triple-negative breast cancer and radiation therapy
por: de Faria Bessa, Jordana, et al.
Publicado: (2022)

Quasi-Poisson versus negative binomial regression models in identifying factors affecting initial CD4 cell count change due to antiretroviral therapy administered to HIV-positive adults in North–West Ethiopia (Amhara region)
por: Seyoum, Awoke, et al.
Publicado: (2016)

Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2
por: Mujwar, Somdutt
Publicado: (2021)

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer
por: Goyette, Marie-Anne, et al.
Publicado: (2019)

Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2019)

Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells
por: Fernandez-Gallardo, Miriam, et al.
Publicado: (2016)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Zinc Favors Triple-Negative Breast Cancer’s Microenvironment Modulation and Cell Plasticity
por: Vogel-González, Marina, et al.
Publicado: (2021)

Functional Proteomic Profiling of Triple-Negative Breast Cancer
por: Gromova, Irina, et al.
Publicado: (2021)

Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro
por: Garza-Morales, Rodolfo, et al.
Publicado: (2018)

Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics
por: Baker, Kristin R., et al.
Publicado: (2019)

Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates
por: Kontou, Angeliki, et al.
Publicado: (2023)

The Relevance of the SH2 Domain for c-Src Functionality in Triple-Negative Breast Cancer Cells
por: Mayoral-Varo, Víctor, et al.
Publicado: (2021)

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
por: Santoro, Marco, et al.
Publicado: (2022)

Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential
por: Esquivel-Ruiz, Sergio, et al.
Publicado: (2021)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4ffphfodecpm4e6ubb6m4vdvuf